| NICE Recommends Votrient® (Pazopanib) For The First-Line Treatment Of Advanced ... - Medical News Today (press release) |
|
|
Medical News Today (press release) Patients in England and Wales living with advanced kidney cancer (renal cell carcinoma - RCC) are one step closer to being able to access Votrient® |